GJB2 mutation spectrum in 2,063 Chinese patients with nonsyndromic hearing impairment.
Pu Dai,Fei Yu,Bing Han,Xuezhong Liu,Guojian Wang,Qi Li,Yongyi Yuan,Xin Liu,Deliang Huang,Dongyang Kang,Xin Zhang,Huijun Yuan,Kun Yao,Jinsheng Hao,Jia He,Yong He,Youqin Wang,Qing Ye,Youjun Yu,Hongyan Lin,Lijia Liu,Wei Deng,Xiuhui Zhu,Yiwen You,Jinghong Cui,Nongsheng Hou,Xuehai Xu,Jin Zhang,Liang Tang,Rendong Song,Yongjun Lin,Shuanzhu Sun,Ruining Zhang,Hao Wu,Yuebing Ma,Shanxiang Zhu,Bai-Lin Wu,Dongyi Han,Lee-Jun C Wong
DOI: https://doi.org/10.1186/1479-5876-7-26
IF: 8.44
2009-01-01
Journal of Translational Medicine
Abstract:In some regions of China, testing of the three most common mutations can identify at least one GJB2 mutant allele in all patients. In other regions such as Tibet, the three most common mutations account for only 16% the GJB2 mutant alleles. Thus, in this region, sequencing of GJB2 would be recommended. In addition, the etiology of more than 80% of the mutant alleles for NSHI in China remains to be identified. Analysis of other NSHI related genes will be necessary.